Masterson steps down
February 20, 2013
THE Chairman of Medicines
Australia, Mark Masterson, will
step down from his role at the end
of February.
Masterson cited a new business
opportunity in a leadership role
within a technology company as his
reason for his resignation.
“It has been an enormous
privilege to serve this great
industry as Medicines Australia
Chairman,” said Masterson.
“The medicines industry in
Australia has navigated some
significant policy and business
challenges during my tenure, and
has shown extraordinary resilience
in the face of those challenges.
In Masterson’s absence, Mark
Fladrich, the MD of AstraZeneca
Australia and NZ, will be acting
Chairman until a new independent
Chair is appointed.
The above article was sent to subscribers in Pharmacy Daily's issue from 20 Feb 13To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Feb 13